Basel, November 20, 2025 – Novartis today rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in ...
The world’s most valuable currency isn’t a luxury item—it’s a moment. As consumers shift their spending from things to experiences, KSL Capital Partners is shaping what the next chapter of travel will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback